Stroke Neuroprotection: Targeting Mitochondria
Stroke is the fourth leading cause of death and the leading cause of long-term disability in the United States. Blood flow deficit results in an expanding infarct core with a time-sensitive peri-infarct penumbra that is considered salvageable and is the primary target for treatment strategies. The o...
Main Authors: | Lora Talley Watts, Richard Justin Garling, Reginald Lloyd, Timothy Duong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-04-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3425/3/2/540 |
Similar Items
-
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
by: Luodan Yang, et al.
Published: (2020-06-01) -
GENE TRANSFER IN TOBACCO MITOCHONDRIA IN VITRO AND IN VIVO
by: Katyshev A.I., et al.
Published: (2012-08-01) -
Methylene blue inhibits nucleation and elongation of SOD1 amyloid fibrils
by: Greta Musteikyte, et al.
Published: (2020-08-01) -
trans-Resveratrol as A Neuroprotectant
by: Ellen L. Robb, et al.
Published: (2010-03-01) -
Methylene blue treatment in experimental ischemic stroke: A mini-review
by: Zhao Jiang, et al.
Published: (2016-01-01)